Extendicare (TSE:EXE – Free Report) had its price target increased by National Bankshares from C$21.50 to C$24.50 in a research note released on Wednesday morning,BayStreet.CA reports. National Bankshares currently has an outperform rating on the stock.
Several other brokerages have also issued reports on EXE. CIBC lifted their price target on shares of Extendicare from C$18.00 to C$22.00 in a report on Thursday, November 13th. TD Securities raised their target price on shares of Extendicare from C$15.00 to C$19.00 in a research report on Thursday, November 13th. Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a report on Monday, September 22nd. Finally, BMO Capital Markets increased their price target on Extendicare from C$15.00 to C$21.00 in a research note on Monday, November 17th. Three investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of C$23.86.
Get Our Latest Research Report on Extendicare
Extendicare Price Performance
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 17th were paid a $0.042 dividend. The ex-dividend date of this dividend was Friday, October 31st. This represents a c) annualized dividend and a dividend yield of 2.3%. Extendicare’s dividend payout ratio is presently 46.60%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- Best Energy Stocks – Energy Stocks to Buy Now
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Golden Cross Stocks: Pattern, Examples and Charts
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Growth Stocks: What They Are, Examples and How to Invest
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
